Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions

Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions

US Patent 11826321 · Granted Nov 28, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthetic chimeric poxviruses2025
Methods for treating baldness and promoting hair growth2025
Analogs of cyclobenzaprine and amitryptilene2024
Methods and compositions for treating depression using cyclobenzaprine2024
Analogs of cyclobenzaprine and amitriptyline2022
Synthetic chimeric poxviruses2022
Methods for treating baldness and promoting hair growth2021
Eutectic formulations of cyclobenzaprine hydrochloride2021
Methods and compositions for treating fatigue associated with disordered sleep u2020
Eutectic formulations of cyclobenzaprine hydrochloride2019
Methods and compositions for treating symptoms associated with post-traumatic st2018
Methods and compositions for treating symptoms associated with post-traumatic st2018